Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 8 of 18
Effect of Prebiotics on the Gut Microbiome Profile and Beta Cell Function
NCT04114357
Community-designed Food Is Medicine for Adults With Diabetes
NCT06503861
POST Facilitation for Community Dwelling Older Adults (POST-RCT)
NCT04070183
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers
NCT04334876
Adhesive Tape Placement on Patients' Masks in the Emergency Department Increases Compliance of Proper Face Mask Use
NCT04812184
Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Dementia
NCT04338750
Online Parent-Report Evaluation of the Effects of Processed Music
NCT05249270
Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia
NCT04309370
The Invia Motion at Cesarean Study
NCT04365452
Unsweetened Sparkling Water and Changes in Sweetness Perception in Adolescents
NCT05966870
Decreasing Delirium Through Music in Critically Ill Older Adults
NCT04182334
Predictors of Recovery Expectancy
NCT04274491
Pain After Proximal Digital Amputation Prevention
NCT04378062
Meibomian Gland Dysfunction Treatment
NCT04229888
Imatinib for Pain in Sickle Cell Anemia
NCT03997903
Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy
NCT04663269
Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs
NCT04170920
Development of Adaptive Vacuum Suspension to Improve Prosthetic Fit and Residual Limb Health
NCT03927404
Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support
NCT03323502
Virtual Reality: Its Effect on Physical Activity Intensity and Pain Sensitivity
NCT04221139
Intermittent Pneumatic Compression to Improve Revascularization Outcome
NCT04250675
Topical Oxygen Therapy for Diabetic Wounds
NCT02313428
Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing
NCT03271580
Sankofa Paradigm: A Therapeutic Theatre Program for Girls
NCT04518397
Beetroot Supplementation in Women Enjoying Exercise Together
NCT04370756
Investigating Interventions to Reduce Residual Opioids in the Home Following Legitimate Opioid Prescribing in Children.
NCT04219397
Brief Informational Intervention for COVID-19 Misinformation Prophylaxis
NCT04557241
Virtual Reality to Improve Social Perspective Taking
NCT03927612
Effect of Epinephrine on Post-polypectomy Pain
NCT04065451
Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
NCT04258423
Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study
NCT04047602
Serratus Anterior Plane Block for Management of Post Thoracotomy Pain
NCT04258436
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer
NCT04187768
Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)
NCT03119259
ESWL Versus SOPIL for Treatment of Pancreatic Duct Stones
NCT04158297
rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia
NCT04182113
Effect of Antibacterial Mouthwash on Muscle Function in Healthy Young Men and Women
NCT04095442
Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy
NCT04300231
Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease
NCT04121858
Effects of ACT OUT! Social Issue Theater on Youth and Adolescents
NCT04097496
Effect of Preoperative Counseling on Postoperative Opioid Use Following Knee Arthroscopy.
NCT04083209
Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides
NCT03789864
Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors
NCT03712813
Vitamin E for NASH Treatment in HIV Infected Individuals
NCT03669133
Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers
NCT04010227
Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections
NCT03846804
Breast Cancer Self-Efficacy Scale for Partners
NCT05228210
Zinc Status and Growth in Cystic Fibrosis
NCT04302428
Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
NCT03983434
Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions
NCT03652636
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.